The dialectic role of progesterone

Maturitas

Volumn 62, Issue 4, 2009, Pages 326-329

  Huber, Johannes C ^a   Ott, Johannes ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Breast cancer; Hormone replacement therapy; Progesterone metabolites; Progesterone receptor

Indexed keywords

20ALPHA HYDROXYSTEROID DEHYDROGENASE; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; 3ALPHA HYDROXYSTEROID DEHYDROGENASE; 3ALPHA(OR 20BETA) HYDROXYSTEROID DEHYDROGENASE; ALANINE; LEUCINE; PREGNANE DERIVATIVE; PROGESTERONE; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; STEROID 5ALPHA REDUCTASE; STEROID 5BETA REDUCTASE; THREONINE; VALINE;

BREAST CANCER; CANCER RISK; CARCINOGENESIS; CODON; DNA POLYMORPHISM; DOWN REGULATION; ENZYME ACTIVITY; ENZYME REPRESSION; EPIGENETICS; GENETIC VARIABILITY; HUMAN; NONHUMAN; PROGESTERONE METABOLISM; REVIEW; UPREGULATION;

BREAST; EPIGENESIS, GENETIC; FEMALE; GENETIC VARIATION; HUMANS; PROGESTERONE; RECEPTORS, PROGESTERONE;

EID: 65249113811     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2008.12.009     Document Type: Review

References (65)

1. Huber J.C. Endokrine Gynäkologie - Einführung in die frauenspezifische Medizin (1998), Wilhelm Maudrich Verlag, Wien - München - Bern
2. Marrone B.L., and Karavolas H.J. Progesterone metabolism by the hypothalamus, pituitary, and uterus of the rat during pregnancy. Endocrinology 109 (1981) 41-45
3. Redmond A.F., and Pepe G.J. Uterine progesterone metabolism during early pseudopregnancy in the rat. Biol Reprod 35 (1986) 949-955
4. Glasier M.A., Wiebe J.P., and Hobkirk R. Progesterone metabolism by guinea pig intrauterine tissues. J Steroid Biochem Mol Biol 51 (1994) 199-207
5. Hobkirk R., Glasier M.A., and Wong M. The effect of chorion-uterine interaction upon free progesterone metabolism during advanced gestation in the guinea pig. J Steroid Biochem Mol Biol 62 (1997) 185-193
6. Sheldrick E.L., Ricketts A.P., and Flint A.P. Placental production of 5 beta-pregnane-3 alpha 20 alpha-diol in goats. J Endocrinol 90 (1981) 151-158
7. Bryson M.J., and Sweat M.L. Metabolism of progesterone in human proliferative endometrium. Endocrinology 81 (1967) 729-734
8. Bryson M.J., and Sweat M.L. Metabolism of progesterone in human myometrium. Endocrinology 84 (1969) 1071-1075
9. Pollow K., Lübbert H., Boquoi E., and Pollow B. Progesterone metabolism in normal human endometrium during the menstrual cycle and in endometrial carcinoma. J Clin Endocrinol Metab 41 (1975) 729-737
10. Milewich L., Gant N.F., Schwarz B.E., et al. Initiation of human parturition VI. Identification and quantification of progesterone metabolites produced by the components of human fetal membranes. J Clin Endocrinol Metab 45 (1977) 400-411
11. Arici A., Marshburn P.B., MacDonald P.C., and Dombrowski R.A. Progesterone metabolism in human endometrial stromal and gland cells in culture. Steroids 64 (1999) 530-534
12. Little B., Dimartinis J., and Nyholm B. The conversion of progesterone to delta 4 pregnene-20 alpha-ol 3-one by human placenta in vitro. Acta Endocrinol (Copenh) 30 (1959) 530-538
13. Wiebe J.P. Progesterone metabolites in breast cancer. Endocr Relat Cancer 13 (2006) 717-738
14. Zmigrod A., Lindner H.R., and Lamprecht S.A. Reductive pathways of progesterone metabolism in the rat ovary. Acta Endocrinol (Copenh) 69 (1972) 141-152
15. Lacy L.R., Knudson M.M., Williams J.J., Richards J.S., and Midgley Jr. A.R. Progesterone metabolism by the ovary of the pregnant rat: discrepancies in the catabolic regulation model. Endocrinology 99 (1976) 929-934
16. Nimrod A. Studies on the synergistic effect of androgen on the stimulation of progestin secretion by FSH in cultured rat granulosa cells: progesterone metabolism and the effect of androgens. Mol Cell Endocrinol 8 (1977) 189-199
17. de la Llosa-Hermier M.P., Leboulleux P., Chene N., and Martal J. Inhibitory effect of ovine and human placental lactogens on progesterone catabolism in luteinized rat ovaries in vitro. Placenta 4 (1983) 479-487
18. Moon Y.S., Duleba A.J., Kim K.S., and Yuen B.H. Effects of prostaglandins E2 and F2 alpha on progesterone metabolism by rat granulosa cells. Biochem Biophys Res Commun 135 (1986) 764-769
19. Wiebe J.P., De Gannes G.C., and Dallaire M.J. Synthesis of the allylic regulatory steroid, 3 alpha-hydroxy-4-pregnen-20-one, by rat granulosa cells and its regulation by gonadotropins. Biol Reprod 50 (1994) 956-964
20. Marrone B.L. Ovarian steroidogenesis in vitro during the first month posthatching in the domestic chick: gonadotropin responsiveness and [3H]progesterone metabolism. Gen Comp Endocrinol 62 (1986) 62-69
21. Wiebe J.P., Buckingham K.D., Zobell R.L., and Hertelendy F. Metabolism of progesterone by avian granulosa cells in culture. J Steroid Biochem Mol Biol 37 (1990) 113-120
22. Sweat M.L., Berliner D.L., Bryson M.J., Nabo Jr. R.S.C., Haskell J., and Holmstrom E.G. The synthesis and metabolism of progesterone in the human and bovine ovary. Biochim Biophys Acta 40 (1960) 289-296
23. Andersson T., and Rafter J. Progesterone metabolism in the microsomal fraction of the testis, head kidney, and trunk kidney from the rainbow trout. Gen Comp Endocrinol 79 (1990) 130-135
24. Canosa L.F., Pozzi A.G., and Ceballos N.R. Pregnenolone and progesterone metabolism by the testes of Bufo arenarum. J Comp Physiol 168 (1998) 491-496
25. Kuwata M., Yamada M., Tamai M., Kitamura Y., and Matsumoto K. Progesterone metabolism in vitro by testes from germ cell-free mice of different ages. Biochim Biophys Acta 486 (1976) 127-135
26. Slaumnwhite Jr. W.R., and Samuels L.T. Progesterone as a precursor of testicular androgens. J Biol Chem 220 (1956) 341-352
27. Wiebe J.P. Isolated Sertoli cells from immature rats produce 20alpha-hydroxy-pregn-4-en-3-one from progesterone and 3beta 20alpha-dihydroxy-5alpha-pregnane from pregnenolone. Biochem Biophys Res Commun 84 (1978) 1003-1008
28. Wiebe J.P., and Tilbe K.S. De novo synthesis of steroids (from acetate) by isolated rat Sertoli cells. Biochem Biophys Res Commun 89 (1979) 1107-1113
29. Wiebe J.P., Tilbe K.S., and Buckingham K.D. An analysis of the metabolites of progesterone produced by isolated Sertoli cells at the onset of gametogenesis. Steroids 35 (1980) 561-577
30. Tilbe K.S., and Wiebe J.P. Sertoli cell capacity to metabolize progesterone: variation with age and the effect of follicle-stimulating hormone. Endocrinology 108 (1981) 597-604
31. Matsumoto K., Yamada M., and Tsujimura T. Progesterone metabolism in vitro by rabbit testes at different stages of development. Endocrinology 99 (1976) 1269-1272
32. Baggett B., Dorfman R.I., Engel L.L., and Savard K. Biosynthesis of androgens from progesterone by human testicular tissue in vitro. J Clin Endocrinol Metab 16 (1956) 1629-1631
33. Stegner H.E., and Lisboa B.P. Steroid metabolism in an androblastoma (Sertoli-Leydig cell tumor): a histopathological and biochemical study. Int J Gynecol Pathol 2 (1984) 410-425
34. Zhong L., Parmer T.G., Robertson M.C., and Gibori G. Prolactin-mediated inhibition of 20alpha-hydroxysteroid dehydrogenase gene expression and the tyrosine kinase system. Biochem Biophys Res Commun 235 (1997) 587-592
35. Gingras S., Moriggl R., Groner B., and Simard J. Induction of 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13. Mol Endocrinol 13 (1999) 66-81
36. Turgeon C., Gingras S., Carrière M.C., Blais Y., Labrie F., and Simard J. Regulation of sex steroid formation by interleukin-4 and interleukin-6 in breast cancer cells. J Steroid Biochem Mol Biol 65 (1998) 151-162
37. Minjarez D., Konda V., and Word R.A. Regulation of uterine 5 alpha-reductase type 1 in mice. Biol Reprod 65 (2001) 1378-1382
38. Makridakis N.M., Ross R.K., Pike M.C., et al. Association of missense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles USA. Lancet 354 (1999) 975-978
39. Makridakis N., Ross R.K., Pike M.C., et al. A prevalent missense substitution that modulates activity of prostatic steroid 5-reductase. Cancer Res 57 (1997) 1020-1022
40. Febbo P.G., Kantoff P.W., Platz E.A., et al. The V89L polymorphism in the 5-reductase type 2 gene and risk of prostate cancer. Cancer Res 59 (1999) 5878-5881
41. Lunn R.M., Bell D.A., Mohler J.L., and Taylor J.A. Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2). Carcinogenesis (Lond) 20 (1999) 1727-1731
42. Yang C., Hamajima N., Iwata H., et al. A49T V89L and TA repeat polymorphisms of steroid 5-reductase type II and breast cancer risk in Japanese women. Breast Cancer Res 4 (2002) R8
43. Scorilas A., Bharaj B., and Giai M. Diamandis EP. Codon 89 polymorphism in the human 5-reductase gene in primary breast cancer. Br J Cancer 84 (2001) 760-767
44. van Gils C.H., Onland-Moret N.C., Roest M., van Noord P.A., and Peeters P.H. The V89L polymorphism in the 5-alpha-reductase type 2 gene and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 12 (2003) 1194-1199
45. Cusan L., Dupont A., Bélanger A., et al. Flutamide in the treatment of female androgenic alopecia. Can J Dermatol 5 (1993) 421-427
46. Labrie F., Luu-The V., Labrie C., et al. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocrine Rev 24 (2003) 152-182
47. Poulin R., Baker D., and Labrie F. Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line. Breast Cancer Res Treat 12 (1988) 213-225
48. Birrell S.N., Bentel J.M., Hickey T.E., et al. Androgens induce divergent proliferative responses in human breast cancer cell lines. J Steroid Biochem Mol Biol 52 (1995) 459-467
49. Kandouz M., Lombet A., Perrot J.Y., et al. Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells. J Steroid Biochem Mol Biol 69 (1999) 463-471
50. Ortmann J., Prifti S., Bohlmann M.K., Rehberger-Schneider S., Strowitzki T., and Rabe T. Testosterone and 5 alpha-dehydrotestosterone inhibit in vitro growth of human breast cancer cell lines. Gynecol Endocrinol 16 (2002) 113-120
51. Di Monaco M., Leonardi L., Gatto V., Gallo M., Brignardello E., and Boccuzzi G. Dehydrotestosterone affects the growth of hormone-unresponsive breast cancer cells: an indirect action. Anticancer Res 15 (1995) 2581-2584
52. Hackenberg R., Lüttchens S., Hofmann J., Kunzmann R., Hölzel F., and Schulz K.D. Androgen sensitivity of the new human breast cancer cell line MFM-223. Cancer Res 51 (1991) 5722-5727
53. Lapointe J., and Labrie C. Role of the cyclin-dependent kinase inhibitor p27(Kip1) in androgen-induced inhibition of CAMA-1 breast cancer cell proliferation. Endocrinology 142 (2001) 4331-4338
54. Boccuzzi G., Tamagno E., Brignardello E., Di Monaco M., Aragno M., and Danni O. Growth inhibition of DMBA-induced rat mammary carcinomas by the antiandrogen flutamide. J Cancer Res Clin Oncol 121 (1995) 150-154
55. Pluchino N., Luisi M., Lenzi E., et al. Progesterone and progestins: effects on brain, allopregnanolone and beta-endorphin. J Steroid Biochem Mol Biol 102 (2006) 205-213
56. Mylonas I., Jeschke U., Shabani L., et al. Steroid receptors ER-alpha, ER-beta PR-A and PR-B are differentially expressed in normal and atrophic human endometrium. Histol Histopathol 22 (2007) 169-176
57. Laduron P.M. Criteria for receptor sites in binding studies. Biochem Pharmacol 33 (1984) 833-839
58. Limbird L.E. Identification of receptors using direct radiogland techniques. Cell surface receptors: a short course on theory and methods. 2nd edn (1996), Klewer Academic Publishers, Norwell, MA
59. Wu Y. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis. Epigenetics 1 (2006) 106-111
60. Bulun S.E., Cheng Y.H., Yin P., et al. Pogesterone resistance in endometriosis: link to failure to metabolize estradiol. Mol Cell Endocrinol 248 (2006) 94-103
61. Sasaki M., Kaneuchi M., Fujimoto S., Tanaka Y., and Dahiya R. Hypermethylation can selectively silence multiple promoters of steroid receptors in cancers. Mol Cell Endocrinol 202 (2003) 201-207
62. Xiong Y., Dowdy S.C., Gonzalez Bosquet J., et al. Epigenetic-mediated upregulation of progesterone receptor B gene in endometrial cancer cell lines. Gynecol Oncol 99 (2005) 135-141
63. Wu Y., Halverson G., Basir Z., Strawn E., Yan P., and Guo S.W. Aberrant methylation at HOXA10 may be responsible for its aberrant expression in the endometrium of patients with endometriosis. Am J Obstet Gynecol 193 (2005) 371-380
64. Izawa M., Harada T., Taniguchi F., Ohama Y., Takenaka Y., and Terakawa N. An epigenetic disorder may cause aberrant expression of aromatase gene in endometriotic stromal cells. Fertil Steril 89 (2008) 1390-1396
65. Liu X., and Guo S.W. A pilot study on the off-label use of valproic acid to treat adenomyosis. Fertil Steril 89 (2008) 246-250